Atlas Trials

The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)

Clinical trial NCT06789757 · RECRUITING

Trial details

NCT number
NCT06789757
Sponsor
Inova Health Care Services
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2025-02-25
Primary completion
2026-10-27
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.